Go Pro
→ Buy These Stocks Before August 31st (From TradeSmith) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
$2.73
+5.0%		$2.42
$0.84
▼
$3.34
$1.51B0.7212.87 million shs14.23 million shs
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
$0.02
$0.02
$0.25
▼
$3.56
$708K2.34455,220 shs60 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
+2.36%+3.59%+16.59%-18.24%+52.49%
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
0.00%0.00%0.00%0.00%-14.29%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
$2.73
+5.0%		$2.42
$0.84
▼
$3.34
$1.51B0.7212.87 million shs14.23 million shs
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
$0.02
$0.02
$0.25
▼
$3.56
$708K2.34455,220 shs60 shs
The 7 Hottest IPO Stories of 2026 Cover
The 7 Hottest IPO Stories of 2026

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
+2.36%+3.59%+16.59%-18.24%+52.49%
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
0.00%0.00%0.00%0.00%-14.29%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
1.78
Reduce$2.53-7.38% Downside
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

Latest ENQ, ENOG, KOS, and SQZ Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/3/2026
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D-)
7/31/2026
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong Sell
7/21/2026
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
Stephens logo
Stephens
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$3.00 ➝ $2.40
5/27/2026
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeNeutral
5/27/2026
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
Mizuho logo
Mizuho
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral ➝ Underperform$2.00 ➝ $3.00
(Data available from 8/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
$1.29B1.26$0.49 per share5.61$1.11 per share2.46
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
$18.16M0.04N/AN/A$1.94 per share0.01
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
-$699.79M-$1.19N/A16.060.19-33.98%-17.73%-2.49%11/2/2026 (Estimated)
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
-$79.46M-$2.61N/AN/AN/A-369.96%-119.83%-59.90%N/A

Latest ENQ, ENOG, KOS, and SQZ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/3/2026Q2 2026
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
$0.0932$0.11+$0.0168$0.31$483.23 million$607.25 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
N/AN/A-100.00%N/AN/A
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
3.58
0.59
0.38
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
N/A
3.50
3.50

Institutional Ownership

CompanyInstitutional Ownership
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
95.33%
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
38.51%

Insider Ownership

CompanyInsider Ownership
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
1.90%
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
16.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
Kosmos Energy Ltd. stock logo
KOS
Kosmos Energy
240595.49 million584.17 millionOptionable
SQZ Biotechnologies stock logo
SQZ
SQZ Biotechnologies
1,62029.49 million24.77 millionNot Optionable

Recent News About These Companies

SQZ Biotechnologies Co.
August 12, 2026  |  barrons.comhttps://www.barrons.com/market-data/stocks/sqzb/research-ratings
Arsenal Yards attracts another life sciences tenant
April 23, 2026  |  bizjournals.comhttps://www.bizjournals.com/boston/news/2026/04/23/als-tdi-watertown-lease.html
Financial Comparison: SQZ Biotechnologies (NYSE:SQZ) vs. Cortexyme (NASDAQ:CRTX)
March 22, 2026  |  defenseworld.netD
Serica Energy reveals impact of Triton downtime, eyes volume recovery “soon”
August 5, 2025  |  proactiveinvestors.co.ukhttps://www.proactiveinvestors.co.uk/companies/news/1076066
SQZB SQZ Biotechnologies Company - Seeking Alpha
July 9, 2025  |  seekingalpha.comhttps://seekingalpha.com/symbol/SQZB
Serica Energy shares drop as Triton suspended until mid-March
February 18, 2025  |  proactiveinvestors.co.ukhttps://www.proactiveinvestors.co.uk/companies/news/1066427
Serica Energy says 2025 outlook is ‘promising'
January 21, 2025  |  proactiveinvestors.co.ukhttps://www.proactiveinvestors.co.uk/companies/news/1064730
Serica Energy expects to remedy “clearly disappointing” recent production performance
January 7, 2025  |  proactiveinvestors.co.ukhttps://www.proactiveinvestors.co.uk/companies/news/1063773
SQZ Biotechnologies Co Ordinary Shares
December 23, 2024  |  morningstar.comM
Portal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round Led by IA Ventures
December 19, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/portal-biotechnologies-announces-over-50-110000254.html
Global Short-Acting Insulin Market is Expected to Cross ~USD 9 Billion by 2030 | DelveInsight
September 5, 2024  |  prnewswire.co.ukP
STEMCELL Launches Novel Cell-Engineering CellPore™ Transfection System
August 1, 2024  |  valdostadailytimes.comV
What is the price tag to keep the biotech engine humming in Massachusetts?
July 23, 2024  |  msn.comhttps://www.msn.com/en-us/news/politics/what-is-the-price-tag-to-keep-the-biotech-engine-humming-in-massachusetts/ar-BB1qtLqc
SQZ Biotechnologies Company (SQZB)
May 22, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/quote/SQZB/news/
Sqz Bio (SQZB) Earnings Dates & Reports
May 8, 2024  |  investing.comhttps://www.investing.com/equities/sqz-biotechnologies-co-earnings
VC funding update: who raised money in March?
April 1, 2024  |  bizjournals.comhttps://www.bizjournals.com/boston/inno/stories/fundings/2024/04/01/vc-funding-update-march-2024.html
SQZ, Portal founder Armon Sharei on starting over in biotech
March 26, 2024  |  biopharmadive.comB
Portal Biotechnologies Announces $5M Pre-Seed Round Led By Pear VC
March 19, 2024  |  finance.yahoo.comhttps://finance.yahoo.com/news/portal-biotechnologies-announces-5m-pre-100000067.html
SQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to Stemcell
March 1, 2024  |  fiercebiotech.comF
SQZB SQZ Biotechnologies Company
December 28, 2023  |  seekingalpha.comhttps://seekingalpha.com/symbol/SQZB/momentum/performance

New MarketBeat Followers Over Time

Media Sentiment Over Time

Kosmos Energy stock logo

Kosmos Energy NYSE:KOS

$2.73 +0.13 (+5.00%)
As of 03:58 PM Eastern

Kosmos Energy Ltd., together with its subsidiaries, engages in the exploration, development, and production of oil and gas along the Atlantic Margins in the United States. The company's primary assets include production projects located in offshore Ghana, Equatorial Guinea, and the U.S. Gulf of Mexico, as well as gas projects located in offshore Mauritania and Senegal. It undertakes a proven basin exploration program in Equatorial Guinea and the U.S. Gulf of Mexico. Kosmos Energy Ltd. was founded in 2003 and is headquartered in Dallas, Texas.

SQZ Biotechnologies stock logo

SQZ Biotechnologies NYSE:SQZ

$0.02 0.00 (0.00%)
As of 08/17/2026

SQZ Biotechnologies Company, a clinical-stage biotechnology company, develops cell therapies for patients with cancer, autoimmune, infectious diseases, and other serious conditions. Its lead product candidate is SQZ-PBMC-HPV, from its SQZ Antigen Presenting Cells platform, which is in a Phase I clinical trial as a monotherapy and in combination with immuno-oncology agents for the treatment of HPV16+ advanced or metastatic solid tumors, including cervical, head-and-neck, anal, penile, vulvar, and vaginal cancer. The company also develops SQZ-AAC-HPV, which is in a Phase I clinical trial for the treatment of HPV16+ advanced or metastatic solid tumors in monotherapy and in combinations with immune-oncology agents. Its additional platforms in development are SQZ Activating Antigen Carriers; and SQZ Tolerizing Antigen Carriers. The Company was incorporated in 2013 and is headquartered in Watertown, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas